Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2012-09-11 18:37:02 UTC |
---|
Update Date | 2022-03-07 02:53:52 UTC |
---|
HMDB ID | HMDB0033844 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | beta-Cryptoxanthin |
---|
Description | beta-Cryptoxanthin has been isolated from abalone, fish eggs, and many higher plants. beta-Cryptoxanthin is a major source of vitamin A, often second only to beta-carotene, and is present in fruits such as oranges, tangerines, and papayas (PMID: 8554331 ). Frequent intake of tropical fruits that are rich in beta-cryptoxanthin is associated with higher plasma beta-cryptoxanthin concentrations in Costa Rican adolescents. Papaya intake was the best food predictor of plasma beta-cryptoxanthin concentrations. Subjects that frequently consumed (i.e. greater or equal to 3 times/day) tropical fruits with at least 50 micro g/100 g beta-cryptoxanthin (e.g. papaya, tangerine, orange, watermelon) had twofold the plasma beta-cryptoxanthin concentrations of those with intakes of less than 4 times/week (PMID: 12368412 ). A modest increase in beta-cryptoxanthin intake, equivalent to one glass of freshly squeezed orange juice per day, is associated with a reduced risk of developing inflammatory disorders such as rheumatoid arthritis (PMID: 16087992 ). Higher prediagnostic serum levels of total carotenoids and beta-cryptoxanthin were associated with lower smoking-related lung cancer risk in middle-aged and older men in Shanghai, China (PMID: 11440962 ). Consistent with inhibition of the lung cancer cell growth, beta-cryptoxanthin induced the mRNA levels of retinoic acid receptor beta (RAR-beta) in BEAS-2B cells, although this effect was less pronounced in A549 cells. Furthermore, beta-cryptoxanthin transactivated the RAR-mediated transcription activity of the retinoic acid response element. These findings suggest a mechanism of anti-proliferative action of beta-cryptoxanthin and indicate that beta-cryptoxanthin may be a promising chemopreventive agent against lung cancer (PMID: 16841329 ). Cryptoxanthin is a natural carotenoid pigment. It has been isolated from a variety of sources including the petals and flowers of plants in the genus Physalis, orange rind, papaya, egg yolk, butter, apples, and bovine blood serum. In a pure form, cryptoxanthin is a red crystalline solid with a metallic lustre. It is freely soluble in chloroform, benzene, pyridine, and carbon disulfide. In the human body, cryptoxanthin is converted into vitamin A (retinol) and is therefore considered a provitamin A. As with other carotenoids, cryptoxanthin is an antioxidant and may help prevent free radical damage to cells and DNA, as well as stimulate the repair of oxidative damage to DNA. Structurally, cryptoxanthin is closely related to beta-carotene, with only the addition of a hydroxyl group. It is a member of the class of carotenoids known as xanthophylls. |
---|
Structure | C\C(\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C InChI=1S/C40H56O/c1-30(18-13-20-32(3)23-25-37-34(5)22-15-27-39(37,7)8)16-11-12-17-31(2)19-14-21-33(4)24-26-38-35(6)28-36(41)29-40(38,9)10/h11-14,16-21,23-26,36,41H,15,22,27-29H2,1-10H3/b12-11+,18-13+,19-14+,25-23+,26-24+,30-16+,31-17+,32-20+,33-21+/t36-/m1/s1 |
---|
Synonyms | Value | Source |
---|
Cryptoxanthin | ChEBI | b-Cryptoxanthin | Generator | Β-cryptoxanthin | Generator | Beta Cryptoxanthin | HMDB | Cryptoxanthins | HMDB | beta-Caroten-3-ol | HMDB | Beta Caroten 3 ol | HMDB | (3R)-Cryptoxanthin | HMDB | (3R)-beta,beta-Caroten-3-ol | HMDB | (3R)-beta-Cryptoxanthin | HMDB | (3R)-Β,β-caroten-3-ol | HMDB | (3R)-Β-cryptoxanthin | HMDB | (R)-all-trans-beta-Caroten-3-ol | HMDB | (R)-all-trans-Β-caroten-3-ol | HMDB | 3-Hydroxy-beta-carotene | HMDB | 3-Hydroxy-β-carotene | HMDB | Caricaxanthin | HMDB | Cryptoxanthine | HMDB | Cryptoxanthol | HMDB | Kryptoxanthin | HMDB | Neo-beta-cryptoxanthin | HMDB | Neo-β-cryptoxanthin | HMDB | all-trans-Cryptoxanthin | HMDB | all-trans-Cryptoxanthol | HMDB | all-trans-Neocryptoxanthin | HMDB | all-trans-Neocryptoxanthol | HMDB | all-trans-beta-Cryptoxanthin | HMDB | all-trans-Β-cryptoxanthin | HMDB | trans-Cryptoxanthin | HMDB | trans-beta-Crytoxanthin | HMDB | trans-Β-crytoxanthin | HMDB | Β-caroten-3-ol | HMDB | beta-Cryptoxanthin | HMDB |
| Show more...
---|
Chemical Formula | C40H56O |
---|
Average Molecular Weight | 552.887 |
---|
Monoisotopic Molecular Weight | 552.433116423 |
---|
IUPAC Name | (1R)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-3-en-1-ol |
---|
Traditional Name | cryptoxanthin |
---|
CAS Registry Number | 472-70-8 |
---|
SMILES | C\C(\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C |
---|
InChI Identifier | InChI=1S/C40H56O/c1-30(18-13-20-32(3)23-25-37-34(5)22-15-27-39(37,7)8)16-11-12-17-31(2)19-14-21-33(4)24-26-38-35(6)28-36(41)29-40(38,9)10/h11-14,16-21,23-26,36,41H,15,22,27-29H2,1-10H3/b12-11+,18-13+,19-14+,25-23+,26-24+,30-16+,31-17+,32-20+,33-21+/t36-/m1/s1 |
---|
InChI Key | DMASLKHVQRHNES-FKKUPVFPSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as xanthophylls. These are carotenoids containing an oxygenated carotene backbone. Carotenes are characterized by the presence of two end-groups (mostly cyclohexene rings, but also cyclopentene rings or acyclic groups) linked by a long branched alkyl chain. Carotenes belonging form a subgroup of the carotenoids family. Xanthophylls arise by oxygenation of the carotene backbone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Tetraterpenoids |
---|
Direct Parent | Xanthophylls |
---|
Alternative Parents | |
---|
Substituents | - Xanthophyll
- Secondary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - beta-Cryptoxanthin GC-MS (1 TMS) - 70eV, Positive | Not Available | 2020-06-30 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - beta-Cryptoxanthin GC-MS ("beta-Cryptoxanthin,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - beta-Cryptoxanthin GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QIT 20V, positive-QTOF | splash10-03e2-0000940000-3f294d1b8006a14a01ff | 2020-07-21 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QIT 1V, positive-QTOF | splash10-0gw0-0000590000-7d729e39216a9256dd6e | 2020-07-21 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 4V, negative-QTOF | splash10-001i-0100390000-6e3ca267c63ed4a7b967 | 2020-07-21 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 7V, positive-QTOF | splash10-0udi-0410290000-a5c664cfd06c2fdd3324 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 10V, positive-QTOF | splash10-0udi-0510490000-039320bed3c92cf5f088 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 15V, positive-QTOF | splash10-0ik9-1940330000-b3ae219429ec53cbcd4d | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 17V, positive-QTOF | splash10-0ik9-1920320000-485587903906f2b18dcb | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 20V, positive-QTOF | splash10-0901-1930100000-4fd08614a2f7381f53d5 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 23V, positive-QTOF | splash10-0cka-1930000000-7f32a39aee17b0a4d9b7 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 25V, positive-QTOF | splash10-07i2-1920000000-83c4e90e75123b21d4e9 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 27V, positive-QTOF | splash10-0aos-1920000000-689e947f9f91e455db44 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 33V, positive-QTOF | splash10-0avj-2910000000-1f4da5545dbcc6e23443 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QTOF 35V, positive-QTOF | splash10-0apj-2910000000-2880fa73a258081c1514 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QqQ 10V, positive-QTOF | splash10-0udi-0000090000-0a3807d0b0e0fcf40e23 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QqQ 12V, positive-QTOF | splash10-0udi-0000190000-c531fb31efc607bca539 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QqQ 14V, positive-QTOF | splash10-0udi-0000290000-9dcfda517e5c18de5c13 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QqQ 16V, positive-QTOF | splash10-0w29-0100590000-8b0595fe54a9ba02ae84 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QqQ 18V, positive-QTOF | splash10-0w29-0531890000-cf871a68617fa4921636 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - beta-Cryptoxanthin QqQ 20V, positive-QTOF | splash10-0ik9-0961640000-22863b9e3dbec1d44800 | 2020-07-22 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cryptoxanthin 10V, Positive-QTOF | splash10-0f79-0423290000-bf7a8e40a11eff7bfe3c | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cryptoxanthin 20V, Positive-QTOF | splash10-0002-0649100000-9c3f50cab7f2d02e22fd | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cryptoxanthin 40V, Positive-QTOF | splash10-002k-0569000000-8a2e2a50f957c26b3ab1 | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cryptoxanthin 10V, Negative-QTOF | splash10-0udi-0000090000-d34ae69e503c3f381911 | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cryptoxanthin 20V, Negative-QTOF | splash10-0udi-0000090000-2fe3377fd40bc851dfc4 | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - beta-Cryptoxanthin 40V, Negative-QTOF | splash10-000i-0546190000-d1d53215d44121d13684 | 2017-06-28 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.16 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.18 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.094 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.181 +/- 0.00500 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.150 +/- 0.0800 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.180 +/- 0.120 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.136 +/- 0.150 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.160 +/- 0.110 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.270 +/- 0.170 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.107 +/- 0.130 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.180 +/- 0.100 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.200 +/- 0.120 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.130 +/- 0.180 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.327 +/- 0.175 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.620 +/- 0.330 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.700 +/- 0.310 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.09 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.09 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 170 +/- 50 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.313 +/- 0.172 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.147 +/- 0.102 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.14 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.16 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.091 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.196 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.245 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.289 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.209 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.23 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.283 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.14 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.141 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.422 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0400 +/- 0.0300 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.130 +/- 0.190 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.150 +/- 0.0850 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.170 +/- 0.112 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.250 +/- 0.350 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.324 +/- 0.174 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.169 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.177 uM | Adolescent (13-18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.18 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.215 uM | Children (1-13 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.27 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.34 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.190 +/- 0.160 uM | Adolescent (13-18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.194 +/- 0.121 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.225 +/- 0.167 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.275 +/- 0.295 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.295 +/- 0.279 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.374 +/- 0.190 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.465 +/- 0.351 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 221.751 +/- 113.408 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.152 uM | Adolescent (13-18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.16 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.17 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.174 uM | Children (1-13 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.23 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.116 +/- 0.0778 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.125 +/- 0.0742 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.148 +/- 0.101 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.150 +/- 0.160 uM | Adolescent (13-18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.167 +/- 0.132 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.181 +/- 0.202 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.203 +/- 0.165 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.259 +/- 0.123 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 130 +/- 90 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 240 +/- 160 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 240.381 +/- 118.291 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.220 +/- 0.210 uM | Children (1 - 13 years old) | Not Specified | Normal | | details | Breast Milk | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
| Show more...
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.103 +/- 0.110 uM | Adult (>18 years old) | Not Specified | Obese | | details | Blood | Detected and Quantified | 0.135 +/- 0.160 uM | Adult (>18 years old) | Not Specified | Overweight | | details | Blood | Detected and Quantified | 0.420 +/- 0.330 uM | Adult (>18 years old) | Both | Type I diabetes | | details | Blood | Detected and Quantified | 0.100 +/- 0.0500 uM | Children (1 - 13 years old) | Not Specified | Obese | | details | Blood | Detected and Quantified | 0.180 +/- 0.110 uM | Children (1 - 13 years old) | Not Specified | Overweight | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Obesity |
---|
- Vioque J, Weinbrenner T, Asensio L, Castello A, Young IS, Fletcher A: Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects. Br J Nutr. 2007 May;97(5):977-86. [PubMed:17408529 ]
- Burrows TL, Warren JM, Colyvas K, Garg ML, Collins CE: Validation of overweight children's fruit and vegetable intake using plasma carotenoids. Obesity (Silver Spring). 2009 Jan;17(1):162-8. doi: 10.1038/oby.2008.495. Epub 2008 Nov 6. [PubMed:18997681 ]
| Diabetes mellitus type 1 |
---|
- Granado-Lorencio F, Olmedilla-Alonso B, Blanco-Navarro I, Botella-Romero F, Simal-Anton A: Assessment of carotenoid status and the relation to glycaemic control in type I diabetics: a follow-up study. Eur J Clin Nutr. 2006 Aug;60(8):1000-8. Epub 2006 Feb 1. [PubMed:16452910 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB097255 |
---|
KNApSAcK ID | C00000920 |
---|
Chemspider ID | 4444647 |
---|
KEGG Compound ID | C08591 |
---|
BioCyc ID | CPD-7409 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Cryptoxanthin |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5281235 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 10362 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | rw1701401 |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Wingerath T, Stahl W, Sies H: beta-Cryptoxanthin selectively increases in human chylomicrons upon ingestion of tangerine concentrate rich in beta-cryptoxanthin esters. Arch Biochem Biophys. 1995 Dec 20;324(2):385-90. [PubMed:8554331 ]
- Irwig MS, El-Sohemy A, Baylin A, Rifai N, Campos H: Frequent intake of tropical fruits that are rich in beta-cryptoxanthin is associated with higher plasma beta-cryptoxanthin concentrations in Costa Rican adolescents. J Nutr. 2002 Oct;132(10):3161-7. [PubMed:12368412 ]
- Pattison DJ, Symmons DP, Lunt M, Welch A, Bingham SA, Day NE, Silman AJ: Dietary beta-cryptoxanthin and inflammatory polyarthritis: results from a population-based prospective study. Am J Clin Nutr. 2005 Aug;82(2):451-5. [PubMed:16087992 ]
- Yuan JM, Ross RK, Chu XD, Gao YT, Yu MC: Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):767-73. [PubMed:11440962 ]
- Child JA: Haematology reporting. Nurs Times. 1975 Jul 3;71(27):1045-8. [PubMed:1144092 ]
- Ruano-Ravina A, Barros-Dios JM, Figueiras A, Branas-Tato P: Correspondence re Yuan JM et al., Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China. 2001;10:767-73. Neuhoser ML et al., Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). 2002;12:350-8. Satia-Abouta J et al., Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. 2003;12:747-54. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):679-80; author reply 680. [PubMed:15066939 ]
- Lian F, Hu KQ, Russell RM, Wang XD: Beta-cryptoxanthin suppresses the growth of immortalized human bronchial epithelial cells and non-small-cell lung cancer cells and up-regulates retinoic acid receptor beta expression. Int J Cancer. 2006 Nov 1;119(9):2084-9. [PubMed:16841329 ]
- Uchiyama S, Sumida T, Yamaguchi M: Oral administration of beta-cryptoxanthin induces anabolic effects on bone components in the femoral tissues of rats in vivo. Biol Pharm Bull. 2004 Feb;27(2):232-5. [PubMed:14758041 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- (). Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.. .
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
| Show more...
---|